← Back to Search

Tobacco Marketplace Study for Cigarette Smoking

N/A
Waitlist Available
Led By Amanda Quisenberry
Research Sponsored by Roswell Park Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adults unable to consent
Individuals who are not yet adults (infants, children, teenagers)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at the time of the session , assessed up to 15 months
Awards & highlights

Study Summary

This trial uses an Experimental Tobacco Marketplace to study the purchase of tobacco products in menthol cigarette smokers. A greater understanding of tobacco product purchasing could help inform possible regulatory actions by the Food and Drug Administration.

Who is the study for?
This trial is for adult menthol cigarette smokers who smoke a brand with a non-menthol version and live in Western New York. It's not for those under 18, pregnant women, prisoners, or anyone unable to consent. People with certain eye conditions like macular degeneration or glaucoma can't join.Check my eligibility
What is being tested?
The study uses an Experimental Tobacco Marketplace to see how menthol cigarette smokers buy tobacco products when given options including flavored and unflavored e-cigarettes. The goal is to understand if banning flavors might lead to quitting smoking or less harm.See study design
What are the potential side effects?
Since this trial involves assessments and questionnaires rather than medical treatments, there are no direct side effects from interventions. However, participants may experience discomfort discussing their smoking habits.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am unable to give consent for myself.
Select...
I am under the age of 18.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at the time of the session , assessed up to 15 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and at the time of the session , assessed up to 15 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Cessation of Menthol flavored cigarettes
Eye tracking metrics

Trial Design

1Treatment groups
Experimental Treatment
Group I: PreventionExperimental Treatment3 Interventions
During the session, participants are presented with randomly ordered conditions: menthol cigarettes and five flavored e-cigarettes (menthol/mint, fruits, sweets, alcohol, snacks/meals), menthol cigarettes and both unflavored and tobacco-flavored e-cigarettes, non-menthol cigarettes and five flavored e-cigarettes, and non-menthol cigarettes and both unflavored and tobacco-flavored e-cigarettes. Participants' visual attention is evaluated by eye-tracking equipment.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Smoking Cessation Intervention
2005
N/A
~1800

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,657 Previous Clinical Trials
40,933,564 Total Patients Enrolled
Roswell Park Cancer InstituteLead Sponsor
402 Previous Clinical Trials
30,755 Total Patients Enrolled
Amanda QuisenberryPrincipal InvestigatorRoswell Park Cancer Institute
1 Previous Clinical Trials
20 Total Patients Enrolled

Media Library

Smoking Cessation Intervention Clinical Trial Eligibility Overview. Trial Name: NCT03897530 — N/A
Smoking/Cigarette Smoking Research Study Groups: Prevention
Smoking/Cigarette Smoking Clinical Trial 2023: Smoking Cessation Intervention Highlights & Side Effects. Trial Name: NCT03897530 — N/A
Smoking Cessation Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT03897530 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there available slots for individuals who wish to participate in this investigation?

"According to official records, this clinical trial is still open for enrolment. The study was first published on the 17th of June 2019 and the data has been updated most recently in September 2022."

Answered by AI

What is the cap on participant capacity in this clinical trial?

"Affirmative. The information on clinicaltrials.gov suggests that this research project is actively enrolling individuals. It was first introduced to the public on June 17th 2019 and its most recent update took place on September 21st 2022. A total of 206 patients will be sought out from 1 site for participation in this trial."

Answered by AI
~18 spots leftby Apr 2025